Peers for comparison


Market capitalization
‪16.19 B‬ USDLarge cap
1.01 USD
‪−144.34 M‬ USD
‪4.02 B‬ USD
‪47.38 M‬
Beta (1Y)
1.39
Last report date
Report period
EPS
Revenue
Earnings release details

Q3 organic revenue rose 4.7% and non-GAAP EPS grew 27.2%, beating prior outlook. FY26 revenue and EPS guidance increased on improving demand, strong DSA bookings and manufacturing recovery.

Employees (FY)
‪19.7 K‬
Change (1Y)
−400−1.99%
Revenue / Employee (1Y)
‪203.83 K‬ USD
Net income / Employee (1Y)
‪−7.33 K‬ USD

Company info


CEO
Birgit Girshick
Website
Headquarters
Wilmington
Founded
1947
IPO date
Jun 23, 2000
ISIN
US1598641074
CUSIP
159864107
FIGI
BBG000BG5BL8
Identifiers
ISIN US1598641074
CFI code
ESVUFR
Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The Research Models and Services segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The Discovery and Safety Assessment segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral
An aggregate view of professional's ratings.
Neutral
Neutral
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Maturity dateMar 15, 2029
Coupon3.75% (Fixed)
Maturity dateMar 15, 2031
Coupon4.00% (Fixed)
Maturity dateMay 1, 2028
Coupon4.25% (Fixed)

See all CRL bonds 

Weight0.02%
Market value‪447.32 M‬
Weight0.02%
Market value‪369.61 M‬
Weight0.18%
Market value‪317.01 M‬
Weight0.24%
Market value‪247.47 M‬
Weight0.02%
Market value‪216.51 M‬
Weight0.32%
Market value‪206.32 M‬
Weight0.02%
Market value‪198.89 M‬
Weight1.11%
Market value‪121.62 M‬
Weight0.24%
Market value‪120.86 M‬
Weight0.12%
Market value‪69.40 M‬
Weight0.07%
Market value‪62.01 M‬

Explore more ETFs 

Frequently asked questions


Charles River Laboratories International, Inc. is scheduled to release its next earnings report on Feb 24, 2027.

Why it matters:
– Key event: Earnings often drive significant price moves
– Market expectations: Traders watch revenue, EPS, and guidance vs forecasts
– Volatility spike: Price swings can increase before and after the release

How to use it:
– Track upcoming reports in the Earnings Calendar
– Compare actual results with analyst estimates
– Monitor price reaction and volume on Supercharts
CRL stock is 2.86% volatile and has beta coefficient of 1.39.

What it means:
– Volatility: Shows how much the price fluctuates over time
– Beta > 1: More volatile than the market
– Beta < 1: Less volatile, more stable

Important to know:
– Volatility can increase during earnings, news events, or market stress
– Large-cap stocks like CRL are typically less volatile than smaller companies

Track every detail on Charles River Laboratories International, Inc. stock chart and check out the list of the most volatile stocks — is Charles River Laboratories International, Inc. there?
To understand the CRL stock performance, it's worth checking price changes for various periods to get the full picture:
– 1 day — −0.83%
– 1 week — +6.04%
– 1 month — +13.59%

CRL all-time low was 17.19 USD (Dec 11, 2000), and its highest price is 460.21 USD (Sep 24, 2021). Find more dynamics in the Stock Heatmap and on the Charles River Laboratories International, Inc. stock chart.
Charles River Laboratories International, Inc. market capitalization is ‪16.19 B‬, representing the total value of all its outstanding shares (price × shares outstanding).

What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements

What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from Charles River Laboratories International, Inc. stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how Charles River Laboratories International, Inc. stacks up against other companies
The safest way to buy Charles River Laboratories International, Inc. stocks is through a reliable broker. Create an account, fund it, and place a buy order.

You can trade CRL directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart

Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.
As of Nov 16, 2026, the company has ‪19.7 K‬ employees.

Why traders follow this data:
– Company scale: Employee count reflects the size and global reach of the business
– Operational footprint: Higher headcount often indicates broader product lines, retail presence, or services
– Trend signal: Changes over time can reflect hiring growth, restructuring, or efficiency improvements

See our rating of the largest employers to find more opportunities.
Investing in Charles River Laboratories International, Inc. depends on your goals, risk tolerance, and market conditions. It’s essential to analyze the stock before making a decision.

First, study Charles River Laboratories International, Inc. financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency

Then explore our CRL technicals – signals based on essential indicators calculations:
– Today — buy
– 1-week — buy
– 1-month — buy

Combine fundamental and technical analysis for better results.
Charles River Laboratories International, Inc. stock ticker depends on the exchange where it’s listed. On the NYSE, its primary exchange, Charles River Laboratories International, Inc. stocks trade under the symbol CRL.

About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners

Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion

Learn how to find your desired assets in our Symbol Search.
CRL earnings for the last quarter are 3.09 USD per share, whereas the estimation was 2.97 USD, resulting in a 3.94% surprise. The estimated earnings for the next quarter are 3.32 USD per share.

How to read financials:
– Compare actual vs estimates: Earnings beats or misses often drive price moves
– Watch market reaction: Price response matters as much as the numbers
– Look at forward guidance: Future estimates signal expected growth
– Track trends: Analyze results across multiple quarters, not just one

Follow other essential metrics in Charles River Laboratories International, Inc. financials:
– Revenue growth: Shows business expansion
– Margins (operating, net): Reflect profitability and efficiency
– Free cash flow: Indicates real cash generation
– Debt levels: Impacts financial stability and risk
Charles River Laboratories International, Inc. revenue for the last quarter amounts to ‪982.73 M‬ USD despite the estimated figure of ‪960.36 M‬ USD. In the next quarter revenue is expected to reach ‪970.24 M‬ USD.

How to read this data:
– Compare actual vs estimates: Revenue beats or misses can move the stock
– Watch market reaction: Price response shows how investors interpret results
– Look at growth: Compare with previous quarters and year-over-year data
– Track trends: One quarter matters less than consistent performance

Follow other essential metrics in Charles River Laboratories International, Inc. financials:
– Earnings (EPS): Profitability per share
– Margins (gross, operating): Efficiency and cost control
– Free cash flow: Cash available after expenses
Yes, you can track Charles River Laboratories International, Inc. financials in yearly and quarterly reports right on TradingView.

Use our Earnings Calendar to never miss important releases and spot opportunities early.
CRL net income for the last quarter is ‪333.07 M‬ USD, while the quarter before that showed ‪−1.48 M‬ USD of net income which accounts for ‪22.57 K‬% change.

How to read this data:
– Track changes: Compare net income across quarters to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one quarter: Consistency matters more than a single result

Follow other essential metrics in Charles River Laboratories International, Inc. financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control
No, Charles River Laboratories International, Inc. does not currently pay dividends to its shareholders.

Instead of distributing profits as cash payments, the company may choose to reinvest earnings back into the business — for example, in growth, innovation, acquisitions, or debt reduction.

What to consider instead:
– Earnings growth: Is the company increasing profitability over time?
– Revenue expansion: Is the business scaling its operations?
– Free cash flow: Does it generate enough cash to potentially support future dividends?
– Share buybacks: Some companies return capital through repurchasing shares instead of dividends
CRL reached its all-time high of 460.21 USD on Sep 24, 2021. Its all-time low was 17.19 USD and was reached on Dec 11, 2000.

Explore the Charles River Laboratories International, Inc. stock price chart to see more price history, and discover companies reaching new all-time highs and lows.
Charles River Laboratories International, Inc. EBITDA is ‪896.17 M‬ USD, with an EBITDA margin of 22.89%.

EBITDA is a measure of core operating performance, showing how much profit the company generates from its main business activities before accounting for financing and accounting-related costs.

What it means:
– Operating strength: Helps assess profitability from core operations
– Efficiency signal: Rising EBITDA often reflects improving business performance
– Comparability: Useful for comparing companies with different capital structures

What to look at next in Charles River Laboratories International, Inc. statements:
– Revenue growth: Shows whether the business is expanding
– Net income: Captures full profitability after all expenses
– Free cash flow: Shows actual cash generated
– Debt levels: Important when evaluating earnings quality
Analyst forecasts suggest a price range between 302.00 USD and 400.00 USD for CRL, based on current estimates.

Remember:
– Forecasts show possible scenarios, not guaranteed outcomes
– They're based on multiple analysts’ models and assumptions
– Target prices change with earnings, news, and market conditions

Don't rely on analysts' opinions alone:
– Use technical analysis: Trend, support/resistance, momentum
– Study fundamentals: Revenue, earnings, margins
– Account for market context: News, macro trends, sector performance